Vapor Phase Hydrogen Peroxide Decontamination or Sanitization of an Isolator for Aseptic Filling of Monoclonal Antibody Drug Product—Hydrogen Peroxide Uptake and Impact on Protein Quality

Reference

1. 1.↵
   International Conference on Harmonization ICH Q8 (R2). Pharmaceutical Development. August 2009.
2. 2.↵
   International Conference on Harmonization ICH Q9. Quality Risk Management. November 2005.
3. 3.↵
   International Conference on Harmonization ICH Q10. Pharmaceutical Quality Systems. June 2008.
4. 4.↵
   1. Jameel F.,
   2. Hershenson S.,
   3. Mansoor K. H.,
   4. Martin-Moe S.

   1. Mansoor C. A.,
   2. Khan A.,
   3. Shah R. B.

   Challenges and Opportunities for Biotech Quality by Design in Quality by Design for Biopharmaceutical Drug Product Development, Jameel F., Hershenson S., Mansoor K. H., Martin-Moe S., Eds.; AAPS Advances in the Pharmaceutical Sciences Series; Springer: NY, 2015.
5. 5.↵
   1. Jameel F.,
   2. Hershenson S.,
   3. Mansoor K. H.,
   4. Martin-Moe S.

   1. Lim F. J.,
   2. Sundaram J.,
   3. Alavattam S.

   Application of Quality by Design Principles to the Drug Product Technology Transfer Process in Quality by Design for Biopharmaceutical Drug Product Development, Jameel F., Hershenson S., Mansoor K. H., Martin-Moe S., Eds.; AAPS Advances in the Pharmaceutical Sciences Series; Springer: NY, 2015.
6. 6.↵
   1. Muller H. J.,
   2. Sommermeyer K.,
   3. Ceck F.

   Permeation of Gaseous Hydrogen Peroxide and Peracetic Acid into IV Bags during Their Surface Sterilization. Hospital Pharmacist 2003, 10 (2), 81–86.

   OpenUrl
7. 7.↵
   1. Meszaros J. E.,
   2. Antloga K.,
   3. Justi C.,
   4. Plesnicher C.,
   5. McDonnell G.

   Area Fumigation with Hydrogen Peroxide Vapor. Appl. Biosafety 2005, 10 (2), 91–100.

   OpenUrl
8. 8.↵
   1. Unger-Bimczok B.,
   2. Kottke B.,
   3. Hertel V.,
   4. Rauschnabel J.

   The Influence of Humidity, Hydrogen Peroxide Concentration, and Condensation on the Inactivation of Geobacillus stearothermophilus Spores with Hydrogen Peroxide Vapor. J. Pharm. Innov. 2008, 3 (2), 123–133.

   OpenUrl
9. 9.↵
   1. Krishna A. K.,
   2. Lodhi S. A.,
   3. Harris M. R.

   Isolator Technology for Research and Development Applications: From Concept to Production. Pharm. Dev. Technol. 2000, 5 (4), 507–520.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Thirumangalathu R.,
    2. Krishnan S.,
    3. Bonderenko P.

    Oxidation of Methionine Residues in Recombinant Human Interleulin-1 Receptor Antagonist: Implication of Conformational Stability on Protein Oxidation Kinetics. Biochemistry 2007, 46 (21), 6213–6224.

    OpenUrl
11. 11.↵
    1. Liu J. L.,
    2. Lu K. V.,
    3. Eris T.

    In Vitro Methionine Oxidation of Recombinant Human Leptin. Pharm. Res. 1998, 15 (4), 632–640.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Simat T. J.,
    2. Steinhart H.

    Oxidation of Tryptophan and Tryptophan Residues on Peptides and Proteins. J. Agric. Food Chem. 1998, 46 (2), 490–498.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Requena J. R.,
    2. Dimitrova M. N.,
    3. Legname G.,
    4. Teijeira S.,
    5. Prusinner S. B.,
    6. Levine R. L.

    Oxidation of Methionine Residues in the Prion Proteins by Hydrogen Peroxide. Arch. Biochem. Biophys. 2004, 432, 188–195.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Mulinacci F.,
    2. Poirier E.,
    3. Capelle M. A.,
    4. Gurny R.,
    5. Arvinte T.

    Influence of Methionine Oxidation on the Aggregation of Recombinant Human Growth Hormone. Eur. J. Pharm. Biopharm. 2013, 85 (1), 42–52.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Ha E.,
    2. Wang W.,
    3. Wang Y. J.

    Peroxide Formation in Polysorbate 80 and Protein Stability. J. Pharm. Sci. 2002, 91 (10), 2252–2264.

    OpenUrlPubMed
16. 16.↵
    1. Kishore R. S.,
    2. Pappenberger A.,
    3. Dauphin I. B.

    Degradation of Polysorbates 20 and 80: Studies on Thermal Oxidation and Hydrolysis. J. Pharm. Sci. 2011, 100 (2), 721–731.

    OpenUrlPubMed
17. 17.↵
    1. Wasylashuk S.,
    2. Harmon P. A.,
    3. Wagner G.,
    4. Harman A. B.,
    5. Templeton A. C.,
    6. Xu H.,
    7. Reed R. A.

    Evaluation of Hydroperoxides in Common Pharmaceutical Excipients. J. Pharm. Sci. 2007, 96 (1), 106–116.

    OpenUrlPubMed
18. 18.↵
    1. Wang W.,
    2. Ignatius A. A.,
    3. Thakkar S. V.

    Impact of Residual Impurities and Contaminants on Protein Stability. J. Pharm. Sci. 2014, 103 (5), 1315–1330.

    OpenUrl
19. 19.↵
    1. Hui A.,
    2. Lam X. M.,
    3. Kuehl C.,
    4. Grauschopf U.,
    5. Wang Y. J.

    Kinetic Modeling of Methionine Oxidation in Monoclonal Antibody from Hydrogen Peroxide Spiking Studies. PDA J. Pharm. Sci. Technol. 2015, 69 (4), 511–525.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Cheng W.,
    2. Zheng X.,
    3. Yang M.

    Hydrogen Peroxide Induced Protein Oxidation during Storage and Lyophilization Process. J. Pharm. Sci. 2016, 105 (6), 1837–1842.

    OpenUrl
21. 21.↵
    1. Hubbard A.,
    2. Eppler K.

    Measuring Hydrogen Peroxide Residuals and Product Exposure on Isolator and RABS Filling Lines. BioPharma Asia 2015, 4, 26–33.

    OpenUrl
22. 22.↵
    1. Radl S.,
    2. Ortner S.,
    3. SungKorn R.,
    4. Khinast J. G.

    The Engineering of Hydrogen Peroxide Decontamination Systems. J. Pharm. Innov. 2009, 4 (2), 51–62.

    OpenUrl
23. 23.↵
    1. Radl S.,
    2. Larisegger S.,
    3. Suzzi D.,
    4. Khinast J. G.

    Quantifying Absorption Effects during Hydrogen Peroxide Decontamination. J. Pharm. Innov. 2011, 6 (4), 202–216.

    OpenUrl
24. 24.↵
    1. Zhang B,
    2. Jeong J.,
    3. Burgess B.,
    4. Jazayri M.,
    5. Tang Y.,
    6. Zhang Y.T.

    Development of a Rapid RP-UHPLC-MS Method for Analysis of Modifications in Therapeutic Monoclonal Antibodies. J. Chromatogr., B 2016, 1032, 172–181.

    OpenUrlCrossRef